It is important to note that obese NASH cirrhotic patients also have sarcopenia and are most insulin resistant and metabolically inflexible.122, 123 They often require more aggressive hypoglycaemic therapy to achieve glycaemic targets but this can worsen adiposity. The gene discussed is INS; the disease is metabolic dysfunction-associated steatohepatitis.